“With increasing global rates of Lyme disease, providing a new option for people to help protect themselves from the disease is more important than ever,” says Annaliesa Anderson, PhD, senior vice president and head of vaccine research & development at Pfizer.

The FDA’s Center for Devices and Radiological Health (CDRH) has updated the status of two previously disaccredited mammography operations, rehabilitating the reputation of one while showing the other in limbo.

The presence of any or all of four factors can help ensure appropriate CT utilization in emergency settings: established diagnostic pathways, alternative test availability, involvement of specialists and feedback from referrers.

The deal brings together one of the biggest pharmaceutical companies in the United States with a biopharmaceutical company specializing in blood disorders.

News of the deal comes after reports that Signify Health is exploring strategic alternatives, including a sale.

Implementing an EHR cancer tracking system to review radiology reports for abnormal findings resulted in patients at one Veterans Affairs Hospital receiving their cancer diagnosis and treatment months earlier than those who were imaged before the system was put into place.

The commoditization of health data raises questions about who is owed what, and in what proportion, when artificial intelligence renders the data clinically useful and thereby financially profitable.

Point-of-care MRI is a worthwhile diagnostic option for emergency departments and ICUs concerned about wait or transport times to access fixed MRI for patients with neuroimaging needs.